Pharma Aids Limited (DSE:PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 565.00
+16.80 (3.06%)
At close: Apr 28, 2026
Pharma Aids Revenue
Pharma Aids had revenue of 142.28M BDT in the quarter ending December 31, 2025, with 17.31% growth. This brings the company's revenue in the last twelve months to 474.48M, up 9.96% year-over-year. In the fiscal year ending June 30, 2025, Pharma Aids had annual revenue of 438.09M with 4.00% growth.
Revenue (ttm)
474.48M
Revenue Growth
+9.96%
P/S Ratio
3.72
Revenue / Employee
5.05M
Employees
94
Market Cap
1.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 438.09M | 16.85M | 4.00% |
| Jun 30, 2024 | 421.23M | 112.74M | 36.54% |
| Jun 30, 2023 | 308.49M | -14.55M | -4.51% |
| Jun 30, 2022 | 323.05M | 42.76M | 15.25% |
| Jun 30, 2021 | 280.29M | 10.72M | 3.98% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambee Pharmaceuticals | 183.57M |
| Indo-Bangla Pharmaceuticals | 221.18M |
| Silco Pharmaceuticals | 431.04M |
| Silva Pharmaceuticals | 356.99M |
| Libra Infusions | 197.03M |
| Advent Pharma | 516.48M |
| Central Pharmaceuticals | 34.45M |
| Techno Drugs | 3.15B |